ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 77 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $250,000 | -57.8% | 24,236 | -60.0% | 0.00% | -100.0% |
| Q1 2020 | $592,000 | -73.1% | 60,516 | -68.3% | 0.00% | -66.7% |
| Q4 2019 | $2,203,000 | +76.2% | 191,164 | -16.7% | 0.00% | +50.0% |
| Q3 2019 | $1,250,000 | -21.0% | 229,426 | +72.4% | 0.00% | 0.0% |
| Q2 2019 | $1,583,000 | +1064.0% | 133,110 | +413.9% | 0.00% | – |
| Q1 2019 | $136,000 | +61.9% | 25,900 | -2.6% | 0.00% | – |
| Q4 2018 | $84,000 | -78.9% | 26,600 | -59.6% | 0.00% | – |
| Q3 2018 | $398,000 | -14.0% | 65,851 | -24.7% | 0.00% | -100.0% |
| Q2 2018 | $463,000 | +143.7% | 87,449 | +167.2% | 0.00% | – |
| Q1 2018 | $190,000 | +287.8% | 32,722 | +78.7% | 0.00% | – |
| Q1 2017 | $49,000 | -15.5% | 18,315 | +29.4% | 0.00% | – |
| Q3 2016 | $58,000 | -79.9% | 14,149 | -84.5% | 0.00% | -100.0% |
| Q2 2016 | $288,000 | – | 91,205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |